CIK 0001680367
- Non-accelerated filer
- Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812575858
- Phone
- +1 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-12 | Hornblower Josiah Director | Sale | −14,057 | $27.27 | $383K | 3,274,385 |
| 2021-05-11 | Schreiber Taylor Chief Executive Officer | Sale | −14,783 | $28.03 | $414K | 2,682,779 |
| 2021-05-11 | Hornblower Josiah Director | Sale | −15,040 | $28.04 | $422K | 3,288,442 |
| 2021-05-10 | Schreiber Taylor Chief Executive Officer | Sale | −8,188 | $26.98 | $221K | 2,697,562 |
| 2021-05-10 | Hornblower Josiah Director | Sale | −8,227 | $26.94 | $222K | 3,303,482 |
| 2021-04-28 | Thomson Erin Ator General Counsel | Sale | −5,000 | $35.00 | $175K | 95,259 |
| 2021-04-28 | Neill Andrew R Chief Financial Officer | Sale | −20,000 | $35.00 | $700K | 51,103 |
| 2021-04-15 | Neill Andrew R Chief Financial Officer | Sale | −24,000 | $30.74 | $738K | 71,103 |
| 2021-04-15 | Thomson Erin Ator General Counsel | Sale | −7,000 | $30.77 | $215K | 100,259 |
| 2021-02-10 | Hornblower Josiah Director | Gift | −20,000 | 3,311,709 | ||
| 2021-01-05 | Pandite Arundathy N. Chief Medical Officer | Option exercise | +1,604 | $0.01 | $16 | 101,907 |
| 2021-01-05 | Pandite Arundathy N. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −1,604 | 4,259 | ||
| 2020-12-22 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +1,286 | 1,286 | ||
| 2020-12-22 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +1,286 | 1,286 | ||
| 2020-12-22 | Thomson Erin Ator General Counsel | Grant or award · Stock Option (Right to Buy) | +14,608 | 14,608 | ||
| 2020-12-22 | DeYoung Casi Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +18,743 | 18,743 | ||
| 2020-12-22 | Pandite Arundathy N. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +27,563 | 27,563 | ||
| 2020-12-22 | Neill Andrew R See Remarks | Option exercise | +4,426 | $0.01 | $44 | 95,103 |
| 2020-12-22 | Neill Andrew R See Remarks | Option exercise · Stock Option (Right to Buy) | −4,426 | 11,063 | ||
| 2020-12-22 | Neill Andrew R See Remarks | Grant or award · Stock Option (Right to Buy) | +14,608 | 14,608 |
Page 16 of 18 · 360 trades